Literature DB >> 4635499

Production of potent anti-Australia antigen sera of high specificity and sensitivity in goats.

G R Dreesman, F B Hollinger, R M McCombs, J L Melnick.   

Abstract

Potent antisera of high specificity and sensitivity were produced, in goats, to purified Australia antigen (Au). The antigen was prepared by one of three methods: (i) pelleting, low pH treatment, isopycnic centrifugation two times in CsCl, and rate zonal centrifugation in sucrose; (ii) same as procedure i, with the exception of the low pH treatment; or (iii) twice banding in CsCl by using a BXIV batch-type zonal centrifuge rotor with subsequent preparative Pevikon electrophoresis. The goat anti-Au sera contained high levels of precipitating antibody as tested by immunodiffusion in agar gel and discontinuous counterimmunoelectrophoresis (DCIE) as well as specific complement-fixing antibody and could be used for routine screening of sera for Au without prior adsorption with Au-negative normal human serum (NHS). Identification of 66 of 70 positive specimens (94.3%) in a panel of 98 coded sera (49 duplicates) with 100% reproducibility was made by using one of the goat anti-Au sera at a dilution of 1:16 in the DCIE method. No false positives were recorded. Low levels of antibody against NHS components were effectively removed by a single adsorption with glutaraldehyde cross-linked NHS.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4635499      PMCID: PMC422350          DOI: 10.1128/iai.5.2.213-221.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  ANTIBODY ACTIVITY IN DIFFERENT CHICKEN GLOBULINS.

Authors:  G DREESMAN; C LARSON; R N PINCKARD; R M GROYON; A A BENEDICT
Journal:  Proc Soc Exp Biol Med       Date:  1965-01

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis.

Authors:  B S Blumberg; B J Gerstley; D A Hungerford; W T London; A I Sutnick
Journal:  Ann Intern Med       Date:  1967-05       Impact factor: 25.391

4.  Viral hepatitis. New light on an old disease.

Authors:  S Krugman; J P Giles
Journal:  JAMA       Date:  1970-05-11       Impact factor: 56.272

5.  The production of antibodies to Australia antigen in mouse ascites fluid.

Authors:  I Millman; J F Ziegenfuss; V Raunio; W T London; A I Sutnick; B S Blumberg
Journal:  Proc Soc Exp Biol Med       Date:  1970-04

6.  The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents.

Authors:  S Avrameas; T Ternynck
Journal:  Immunochemistry       Date:  1969-01

7.  Assay of Australia antigen and antibody employing double-antibody and solid-phase radioimmunoassay techniques and comparison with the passive hemagglutination methods.

Authors:  F B Hollinger; V Vorndam; G R Dreesman
Journal:  J Immunol       Date:  1971-10       Impact factor: 5.422

8.  An antigen detected in the blood during the incubation period of serum hepatitis.

Authors:  A M Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1968-07       Impact factor: 11.205

9.  Preparation and characterization of complement-fixing hepatitis-associated antigen and antiserum.

Authors:  R H Purcell; J L Gerin; P V Holland; W L Cline; R M Chanock
Journal:  J Infect Dis       Date:  1970-02       Impact factor: 5.226

10.  Production of antibody against "Australia antigen" in rabbits.

Authors:  L Melartin; B S Blumberg
Journal:  Nature       Date:  1966-06-25       Impact factor: 49.962

View more
  17 in total

1.  Cell-mediated immunity in guinea pigs to subunits derived from hepatitis B surface antigen.

Authors:  G A Cabral; R Chairez; F Marciano-Cabral; M Suarez; G R Dreesman; J L Melnick; F B Hollinger
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

2.  Large-scale purification of hepatitis B surface antigen.

Authors:  J Vnek; A M Prince
Journal:  J Clin Microbiol       Date:  1976-06       Impact factor: 5.948

3.  The interaction between native serum albumin and hepatitis B virus.

Authors:  X Y Lu; G B Yao; Y F Tian
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

4.  Nature of immunological non-responsiveness to hepatitis B vaccine in healthy individuals.

Authors:  S S Chiou; K Yamauchi; T Nakanishi; H Obata
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

5.  Induction of hepatitis B antibody in experimental animals by immunization with A-2 plaque virus.

Authors:  E D Shaw; A P McKee; M Rancourt; L Hollenbeck
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

6.  Concentration and purification of hepatitis B antigen with polyethylene glycol and polyelectrolyte 60, a cross-linked copolymer of isobutylene maleic anhydride.

Authors:  E De Rizzo; R Pandey; C Wallis; J L Melnick
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

7.  Interactions of standard antibody with Australia antigens in Au Ag-Ab radioimmunoassay.

Authors:  H Daugharty; R G Young; M H Hatch; D W Ziegler
Journal:  Appl Microbiol       Date:  1974-04

8.  A simple procedure for purification of hepatitis B-antigen.

Authors:  A Cruceanu; R Müller; H Deicher
Journal:  Med Microbiol Immunol       Date:  1973-09-26       Impact factor: 3.402

9.  Comparative biophysical studies of hepatitis B antigen, subtypes adw and ayw.

Authors:  R Chairez; F B Hollinger; J P Brunschwig; G R Dreesman
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

10.  Biophysical and biochemical heterogeneity of purified hepatitis B antigen.

Authors:  G R Dreesman; F B Hollinger; J R Suriano; R S Fujioka; J P Brunschwig; J L Melnick
Journal:  J Virol       Date:  1972-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.